Pharmacokinetics study of Donepezil HCl in subjects receiving haemodialysis.
Phase 4
- Conditions
- Renal Failure
- Registration Number
- JPRN-jRCT1080221230
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
end-stage renal disease who were receiving haemodialysis.
-Subject who are able and willing to give written informed consent.
Exclusion Criteria
-Subjects with known hypersensitivity to drugs or foods.
-Subjects with a corrected QT interval greater than 450msec at screening period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics parameters
- Secondary Outcome Measures
Name Time Method